ViiV Healthcare has tapped a new mind for its “PrEP Wisdom” campaign, with Tony Award-winning actor and fashion icon Jeremy ...

Novartis has confirmed a number of new cases of tumors that developed in children treated with its gene therapy Zolgensma ...

Moderna’s third quarter proves COVID can still prove a viable source of revenue. | Moderna posted $1.3 billion in third quarter revenue, vastly surpassing analyst estimates and avoiding a predicted ...

The team at Evercore ISI, for its part, claimed Rasonque’s debut was nothing short of “eye-popping.” The shop is now looking at a potential $500 million in Rasonque sales for the year’s final quarter, ...

AstraZeneca may not need a major acquisition to sustain growth beyond 2030—but the British pharma is reportedly not stopping ...

Alnylam Pharmaceuticals is seeking a new chief commercial officer as the biopharma announced that its six-year CCO veteran ...

ANI Pharmaceuticals is forking over more than half a billion dollars to broaden its rare disease business. | ANI ...

Knudsen’s departure will mark the end of a 27-year run at Novo, with Doustdar telling analysts Wednesday that the outgoing ...

Amid surging sales of Rezdiffra, Madrigal Pharmaceuticals is facing a whistleblower lawsuit alleging that senior leadership ...

Merck & Co. is chasing the finish line with its eye on one prize: a world without cancer. | In “From Our Pipeline to the ...

Vanda Pharmaceuticals’ action-packed TV ad for motion-sickness drug Nereus has irked the FDA, which accused (PDF) the company ...

Would you know the difference between a normal cold and one that has turned into something more serious? | Would you know the ...